HOME >> BIOLOGY >> NEWS
A transplant in time

In hemophilia, a mutated gene prevents the production of a critical blood-clotting protein. Treatments for hemophilia and other such genetic diseases, when they exist, may consist of risky blood transfusions or expensive enzyme replacement therapy. But what if the body could be induced to begin producing these proteins, say by transplanting healthy tissue with the abilities that are lacking?

Prof. Yair Reisner and Ph.D. student Anna Aronovich of the Weizmann Institute's Immunology Department, together with colleagues, showed, in research recently published in the Proceedings of the National Academy of Sciences (PNAS), how such a transplant might, in the future, be made feasible.

Previous attempts to treat genetic disease by transplanting (mother to daughter) a spleen, an organ that can manufacture a number of the missing proteins in some such diseases, had made little headway due to the fact that the spleen is home to the immune system's T cells cells responsible for the severe immune responses against the recipient known as graft-versus-host disease (GVHD).

Reisner and his team revived the idea, with a twist. Over the past several years, he and members of his lab have been experimenting with tissue transplanted from pig embryos a possible substitute for human donor organs. From this, they have learned that for each type of tissue, there is a window of opportunity during which cells taken from the developing embryo can be most successfully transplanted. Tissues taken too early, when they are still fairly undifferentiated, may form tumors, while those taken too late can be identified as foreign, causing the host to reject them.

By taking spleen tissue from embryonic pigs over the course of gestation, they found that the harmful T cells are not present in the tissue prior to day 42 of gestation. The scientists also found that tissue of this age exhibits optimal growth potential as well as secreting factor VIII, the blo
'"/>

Contact: Jennifer Manning
jennifer@acwis.org
212-895-7952
American Committee for the Weizmann Institute of Science
28-Dec-2006


Page: 1 2

Related biology news :

1. First case of successful ovarian tissue transplantation between two, nonidentical sisters
2. A faster way to recover from chemotherapy and marrow transplant
3. Data presented at ISHLT meeting confirm RNA analysis can identify rejection in lung transplant recip
4. Scientists identify key to integrating transplanted nerve cells into injured tissue
5. Gene test shown to measure heart function after transplant
6. U of MN adult stem cell research shows promise for transplant therapies
7. Researchers create genetically matched embryonic stem cells for transplantation
8. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
9. Long-term cancer risk follows stem cell transplant recipients
10. Proteins may predict lung transplant rejection
11. Study could help transplant surgeons predict rejection/tailor medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader ... platform that uses artificial intelligence (AI) and a data-centric approach to decentralize medicine ... ulcerative colitis. , People will Crohn’s or other chronic medical conditions join a ...
(Date:1/14/2019)... ... January 14, 2019 , ... Join the live session ... about key topics in data quality, including:, ,     State of ... ,     Smartphone and wearable based performance measures ,     Data quality analytics ...
(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... and compliance solutions, is proud to welcome Thomas Kennedy as head of sales ... Miglicco, CEO for PureWay. , Mr. Kennedy has previously worked for Johnson & ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... January 11, 2019 , ... ... for the automated collection of donor blood. This advanced and intuitive medical ... The unit incorporates the functionality needed for the busiest donor stations with new-to-the ...
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/10/2019)... ... January 08, 2019 , ... VGI Medical was founded in ... leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The ... by utilizing a unique patented dual geometric design to limit motion of the affected ...
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene and Cell ... a selection committee made up of industry leaders identified by the ASGCT board of ... mentored awards created to support ASGCT members designing transformative pilot studies in gene and ...
Breaking Biology Technology:
Cached News: